---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-111212"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:15:33.188711+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius Pharmaceuticals regains Nasdaq compliance on bid price rule

## Summary
- Received Nasdaq notice on Dec 18, 2024 confirming compliance with Listing Rule 5550(a)(2).
- Stock closed at $1.00 or more for 12 consecutive trading days from Nov 26 to Dec 12, 2024.
- Nasdaq stated the matter is now closed.

## SEC filing metadata
- accession: 0001213900-24-111212
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/0001213900-24-111212-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/ea0225393-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-111212
- JSON: https://secwatch.observer/filing/0001213900-24-111212.json
- Plain text: https://secwatch.observer/filing/0001213900-24-111212.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.